Haemonetics
HAE
#2913
Rank
$5.59 B
Marketcap
$122.86
Share price
1.60%
Change (1 day)
65.13%
Change (1 year)

EPS for Haemonetics (HAE)

EPS in 2026 (TTM): $2.27

According to Haemonetics's latest financial reports the company's current EPS (TTM) is $2.27. In 2025 the company made an earnings per share (EPS) of $3.66 an increase over its 2024 EPS that were of $2.56.

EPS history for Haemonetics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$2.27-37.84%
2025$3.6642.68%
2024$2.562.43%
2023$2.5033.73%
2022$1.87332.49%
2021$0.43
2018$0.89-363.15%
2017-$0.34-207.1%
2016$0.32-132.28%
2015-$0.98-269%
2014$0.58-20%
2013$0.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68 193.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$4.08 79.41%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
$18.99 735.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-$1.41-162.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
$3.60 58.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
$9.45 315.54%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
$7.70 238.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
-$0.03000-101.32%๐Ÿ‡บ๐Ÿ‡ธ USA